Skip to main content

Table 2 Proteins differentially expressed between female and male saliva

From: A proteomics informed by transcriptomics insight into the proteome of Ornithodoros erraticus adult tick saliva

Functional category

Accession

Description

Mean signal peak area × 103 (n = 3)—female

Mean signal peak area × 103 (n = 3)— male

Fold change (female/male)

P-valuea

Antimicrobial

ACB70385

Hebreain-like protein

95.60

313.28

0.31

1.31E−02

Antioxidant/detoxification

B7PHC3

Carbon–nitrogen hydrolase, putative

2086.45

320.63

6.51

3.10E−02

PRD32710

Mitochondrial amidoxime reducing component 2

755.23

160.62

4.70

2.83E−03

B7PQF4

Sulfotransferase, putative

30.34

73.69

0.41

1.86E−02

B7QGH2

Glutathione S-transferase, putative

161.86

495.61

0.33

6.81E−03

ABI52820

Superoxide-dismutase

99.49

325.97

0.31

1.88E−02

AWM72026

Catalase 1

716.85

2,616.34

0.27

2.61E−02

RZF47230

Hypothetical protein LSTR_LSTR004939

84.68

684.44

0.12

3.09E−06

Cytoskeletal

ABP01547

beta-Actin

631.00

966.00

0.65

4.54E−02

Extracellular matrix

AAS01023

Mucin/peritrophin-like protein precursor

81.49

0.05

1,644.20

4.72E−02

XP_015907551

Laminin subunit beta-1 isoform X1

123.26

0.24

524.48

4.34E−02

B7Q2R9

Cell adhesion molecule, putative

14.83

51.41

0.29

2.66E−03

Glycine rich

B7Q6J2

Glycine proline-rich secreted protein, putative

2406.02

748.22

3.22

3.30E−02

Heme/iron binding

AXP34687

Vitellogenin-1

6447.77

4.84

1333.20

3.47E−02

AJR36491

Hemelipoglyco-carrier protein CP3

3552.23

8.50

418.01

2.25E−03

ISCW021710-PA

CP3

866.12

25.82

33.54

8.62E−05

AXP34690

Vitellogenin-B

1595.72

357.35

4.47

3.18E−02

Immune related

B7Q4R4

Double sized immunoglobulin G binding protein A

3993.51

779.57

5.12

1.32E−02

DAA34752

Ixodegrin

44.01

135.43

0.32

3.96E−02

AAM54048

Savignygrin

92.22

1021.83

0.09

4.38E−06

Lipocalin

ABI52661

Lipocalin

785.86

196.68

4.00

1.10E−04

ACB70384

Salivary lipocalin

2161.01

667.58

3.24

3.86E−02

ACB70386

Salivary lipocalin, partial

94.71

31.31

3.03

2.93E−02

ADI60053

Savicalin

2749.89

2389.58

1.15

1.60E−04

ABR23414

Moubatin-like 3

203.26

406.82

0.50

6.81E−03

ABI52654

Monotonin

1149.91

2585.77

0.44

7.50E−04

B7QAQ5

Putative uncharacterised protein (fragment)

28.73

99.58

0.29

2.29E−03

ABR23394

Truncated salivary lipocalin, partial

15.89

84.78

0.19

2.24E−03

ABR23399

Moubatin 1-like 2

466.29

6239.00

0.07

2.10E−03

ABR23443

Salivary secreted lipocalin

35.76

1031.18

0.03

2.63E−03

ABR23457

Moubatin-like 5

12.16

5932.07

0.00

1.12E−03

Metabolism, amino acids

TDG38496

Hypothetical protein AWZ03_015082

486.14

3401.02

0.14

1.70E−04

Metabolism, carbohydrates

B7QBY6

Glyoxalase, putative

41.51

96.62

0.43

1.22E−02

XP_013777447

Glucose-6-phosphate isomerase

271.80

808.75

0.34

7.15E−03

DAA34560

Malate dehydrogenase

81.64

330.49

0.25

7.34E−06

B7PLL4

Fructose-1,6-bisphosphatase, putative

128.30

534.11

0.24

1.21E−03

B7Q0R0

Phosphoglycerate mutase, putative

238.67

1208.54

0.20

2.08E−03

AIW65719

Phosphoglucomutase, partial

15.03

89.67

0.17

3.46E−05

ADD91327

Enolase

474.65

2936.96

0.16

2.40E−04

ISCW015616-PA

3-Phosphoglycerate kinase, putative

437.28

2707.91

0.16

1.70E−04

B7Q3K7

Tpi description

240.42

1591.72

0.15

3.25E−05

ISCW020197-PA

Pyruvate kinase, putative

273.95

3468.12

0.08

1.74E−03

ASV64058

Fructose-1,6-bisphosphate aldolase

917.27

15,028.55

0.06

1.20E−04

Metabolism, energy

KDR16306

Glycogen debranching enzyme, partial

109.61

280.36

0.39

7.04E−03

ISCW018700-PA

Glyceraldehyde 3-phosphate dehydrogenase, putative

659.81

5964.82

0.11

1.30E−03

Metabolism, lipids

KFM77310

Apolipoprotein B-100, partial

314.75

3.03

103.96

1.56E−02

ACB70350

Phospholipase A2, partial

264.73

67.48

3.92

1.39E−02

AGJ90343

Phospholipase A2

3359.95

3070.84

1.09

2.13E−03

ABI52805

Phospholipase A2, partial

328.61

812.17

0.40

3.45E−02

ABR23453

Phospholipase A2

7.81

21.19

0.37

1.15E−02

CAX51408

Hypothetical protein, partial

39.25

113.37

0.35

2.93E−02

XP_015915960

Phosphatidylinositol transfer protein alpha isoform

2.92

45.86

0.06

4.20E−03

Metabolism, nucleic acids

B7PCV9

Lysosomal acid phosphatase, putative

2148.64

1148.01

1.87

5.67E−03

ABS30897

5′-Nucleotidase/putative apyrase isoform 2 precursor

270.86

191.26

1.42

4.18E−03

AGJ90350

Apyrase

232.08

234.82

0.99

3.72E−02

B7PJJ3

Adenosine deaminase, putative

95.83

391.27

0.24

6.30E−04

Nuclear regulation

AHN53412

Histone H2B

7.83

22.10

0.35

3.12E−02

XP_017008549

Histone H4-like, partial

2.16

33.42

0.06

4.00E−04

Protease

B7PF28

Longipain, putative

63.26

0.13

500.99

2.57E−02

AMO02552

Carboxypeptidase Q

86.22

1.90

45.40

4.53E−02

ABO26562

Cathepsin L-like cysteine protease

659.14

131.99

4.99

1.26E−02

ISCW004835-PA

Coagulation factor precursor, putative

294.51

60.38

4.88

2.15E−02

XP_013774340

Carboxypeptidase E-like

270.53

117.03

2.31

3.47E−02

B7PJ51

Serine carboxypeptidase, putative (Fragment)

1492.78

648.27

2.30

1.90E−03

XP_019696599

Neprilysin-1

97.36

43.48

2.24

2.21E−02

ABI52714

Metalloprotease, partial

450.02

211.19

2.13

3.26E−02

B7QLA0

Riddle, putative (fragment)

1308.48

3209.73

0.41

4.00E−03

Protease inhibitor

ABI94058

Serpin-8 precursor

49.66

2.44

20.35

2.89E−03

XP_015907865

Hemocytin

7161.53

1838.73

3.89

4.29E−02

B7P6X9

Hemolectin, putative (fragment)

1431.00

1045.88

1.37

3.44E−02

KFM64508

Hemocytin, partial

631.61

667.75

0.95

4.25E−02

AAS01022

Putative thyropin precursor

2472.52

4434.56

0.56

1.26E−02

P83516

Chymotrypsin-elastase inhibitor ixodidin

382.07

759.34

0.50

2.26E−03

XP_022121224

Hemocytin

70.57

173.91

0.41

4.28E−02

XP_023217368

Leukocyte elastase inhibitor A-like isoform X2

19.51

52.26

0.37

4.18E−03

XP_022255312

Hemocytin-like

22.22

62.06

0.36

7.08E−03

ACB70299

Ixodidin

16.77

89.06

0.19

1.88E−03

AAS01021

Cystatin precursor

167.09

1216.49

0.14

1.15E−03

XP_020288964

Chymotrypsin inhibitor-like

195.85

1493.56

0.13

1.73E−02

ACF57858

Chymotrypsin inhibitor precursor

233.56

3678.45

0.06

1.37E−03

Protein modification

B7PWF5

Heat shock protein 20.5, putative

113.92

5.08

22.43

4.59E−02

B7PAR6

Heat shock protein, putative

222.48

1285.43

0.17

2.46E−03

Signal transduction

XP_021001474

Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1

158.76

8.41

18.89

7.25E−03

Transporter/receptors

AGQ57038

Vitellogenin receptor

651.87

25.70

25.37

3.94E−06

XP_015908566

Low-density lipoprotein receptor-related protein 2

107.78

53.93

2.00

1.88E−03

XP_018014210

Very low-density lipoprotein receptor-like

783.98

924.47

0.85

1.22E−02

B7PL51

ML domain-containing protein, putative

93.47

491.13

0.19

4.30E−04

Unknown function

XP_023240426

Synaptogenesis protein syg-2-like

137.70

1.41

97.65

3.88E−03

ACB70374

Putative salivary secreted protein, partial

1704.00

91.42

18.64

2.08E−02

ABI52697

7 cysteine domain

213.20

134.32

1.59

1.96E−03

ABR23379

Salivary basic tailless protein

1124.06

1987.85

0.57

9.02E−05

XP_023213207

Transmembrane protein 241-like

70.75

178.42

0.40

9.99E−03

AAS94230

Unknown secreted protein PK-26 precursor

13,381.20

43,089.64

0.31

2.25E−02

ABR23361

Acid tail salivary protein

14.64

53.69

0.27

3.47E−03

B7PLB9

Secreted protein, putative

502.91

4091.22

0.12

6.10E−04

ACB70369

Acid tail salivary protein

11.20

151.34

0.07

9.36E−05

XP_022900755

S-phase kinase-associated protein 1

189.20

5274.83

0.04

2.50E−04

  1. aP < 0.05